Break the Bottleneck: Automate Plasmid Maxi-prep with AmMag™ Quatro

Our second webinar, entitled Downstream AAV Production: A Targeted Approach to Optimization takes place on Thursday, March 24 at 9.00am ET. Join us as we highlight our multifaceted approach to downstream purification including separation of genome containing (full) from genome-free (empty) AAV capsids and a selection of innovative purification solutions to improve yield, purity and throughput.

Viruses outnumber bacteria in soil by as much as 1000:1. However, there are few studies which examine the ways viral communities impact the soil microbiome, chemical cycles, and plants. Recent advances in viral ecology make it a discussion of soil viral ecology especially timely.

The accelerated expansion of manufacturing facilities needed for COVID-19 vaccines has driven the implementation of single-use technology (SUT) across many sites worldwide.

The COVID-19 pandemic has shown the world that the effectiveness of mRNA vaccine technology is undeniable. The potential for these vaccines to efficiently treat a wide range of communicable diseases is enormous, and the technology is poised to explode into the marketplace. However, effective mRNA vaccines are only as good as the materials and methodologies used to create them, as well as the analytical steps used to test their potency, stability, and clinical efficacy. Traditional analytical methods are slow and end up wasting investigators’ time and money. Advanced imaging and analysis platforms may hold the key to simplifying vaccine development and manufacturing bottlenecks, as they are fast and can be multiplexed to answer multiple scientific questions per analysis.